Skip to main content
51°
Rain
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
27.87
+0.09 (+0.32%)
Streaming Delayed Price
Updated: 11:39 AM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
2024 Promises To Bring Pharmaceutical Breakthroughs On The Oncology Front
February 07, 2024
On Thursday, Merck & Co Inc (NYSE: MRK) topped estimates with its fourth quarter revenue and adjusted earnings fueled by its blockbuster cancer drug Keytruda, along with HPV prevention vaccine...
Via
Benzinga
Want to Earn $2,000 in Annual Dividend Income? Invest $33,000 in These 3 Stocks.
February 07, 2024
These dividend stocks haven't been great performers over the past year, but they could be excellent investments to buy and hold for the long run.
Via
The Motley Fool
3 Biotech Stocks to Buy on the Dip: February 2024
February 07, 2024
Here are three biotech stocks to buy that are trading at prices that may not account for potential breakthrough opportunities
Via
InvestorPlace
Want to Get Richer? Here Are the 3 Best Stocks to Buy Now and Hold Forever
February 07, 2024
Healthcare is an excellent place to find some tried and true wealth compounders.
Via
The Motley Fool
7 Retirement Stocks to Buy at 52-Week Lows
February 06, 2024
Markets may be at historic highs, but there are still plenty of high-quality retirement stocks to buy today at compelling valuations.
Via
InvestorPlace
Topics
Retirement
Exposures
Pension
Spotlight on Pfizer: Analyzing the Surge in Options Activity
February 05, 2024
Via
Benzinga
Is the Worst Over for Pfizer?
February 01, 2024
Pfizer shares sank 43% last year.
Via
The Motley Fool
3 Reliable Dividend Stocks With Yields Above 6% That You Can Buy for Less Than $100 Right Now
February 06, 2024
You don't have to already be rich to start building a significant passive income stream.
Via
The Motley Fool
The 7 Best Healthcare Stocks to Invest In for Big Gains in 2024
February 06, 2024
Invest in the future with healthcare stocks 2024; offering a blend of market stability and cutting-edge medical advancements.
Via
InvestorPlace
3 Magnificent Ultra-High-Yield Dividend Stocks That Are Screaming Buys in February
February 06, 2024
These high-octane income stocks, which sport an average yield of 7.34%, can pad patient investors' pocketbooks.
Via
The Motley Fool
3 Sleeper Stocks to Buy for the Next Bull Run: February 2024
February 05, 2024
Embark on a savvy investing as we uncover three sleeper stocks and chart their stellar long-term potential to perform.
Via
InvestorPlace
3 Magnificent Stocks to Buy on the Dip: February 2024
February 05, 2024
Although the market doesn’t seem to appreciate these stocks to buy on dip, it’s missing out on potentially robust opportunities.
Via
InvestorPlace
NVO, LLY or AZN: Which Pharma Stock Is the Best Weight-Loss Investment?
February 05, 2024
The relaunch of Wegovy last year caused a mad dash by weight loss stocks to compete for market leadership in anti-obesity drugs.
Via
InvestorPlace
Better Dividend Stock: Pfizer vs. AbbVie
February 05, 2024
Both offer above-average yields but which can deliver the most dividend income over the long run?
Via
The Motley Fool
CytoReason's AI-Driven Disease Model Platform Trusted By 5 Top 10 Pharma Companies Harnesses Big Data To Speed Drug Discovery And Development
February 05, 2024
Click here to learn more about CytoReason and how to invest through OurCrowd.
Via
Benzinga
The Bull Market Left These 3 Stocks Behind, but They're Buys Right Now
February 04, 2024
Sometimes, undervalued market laggards have what it takes to catch up over the long haul.
Via
The Motley Fool
1 Beaten-Down Dividend Stock to Avoid in 2024, and 1 to Consider Buying and Holding Forever
February 04, 2024
These two companies have dramatically different futures in store.
Via
The Motley Fool
3 Fabulous Dividend Stocks to Buy in February
February 04, 2024
These stocks offer great dividends and more.
Via
The Motley Fool
Benzinga Bulls And Bears: Meta, Tesla, AMD And Crypto Analyst Predicts That 'DOGE Is Gonna Pop'
February 03, 2024
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
Via
Benzinga
Recent Stock Purchase January 2024
February 02, 2024
With February already underway and the markets on a nice uptrend, I decided to add to some of my lagging existing positions.
Via
Talk Markets
Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations
February 02, 2024
The Inflation Reduction Act's impact on drug prices. Medicare challenges pharmaceutical costs, offering relief to seniors and addressing the soaring prices in the U.S. healthcare system.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Stock Market Handles Huge Earnings Week, Fed's Powell, Jobs Report: Weekly Review
February 02, 2024
The Dow led the major indexes higher. Big techs diverged on results.
Via
Investor's Business Daily
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Bristol Myers Shares Rise On Fourth-Quarter Earnings Beat
February 02, 2024
Bristol Myers earnings came in above expectations, although Opdivo sales were slower than expected. BMY stock gained.
Via
Investor's Business Daily
Million-Dollar Bets: 7 Stocks to Buy Before They Blast Off
February 02, 2024
Seven stocks set to soar: Foundries to pharma, finance's evolution, and digital transformation—unlock million-dollar opportunities.
Via
InvestorPlace
Pfizer Surprises With Profit But Revolutionizing Cancer Treatment Is Its Best Chance Of Getting Back In The Saddle
February 01, 2024
On Tuesday, Pfizer Inc (NYSE: PFE) reported mixed results for its fourth quarter. Last year, Pfizer has responded to concerns related to its COVID-19 products being the rearview mirror with a...
Via
Benzinga
Exposures
COVID-19
Pfizer’s 2024 Comeback: A Dividend Gem in the Pharma Market
February 01, 2024
Pfizer is in Wall Street's doghouse, but don't despair. At its current price, value seekers ought to relish the opportunity to buy PFE stock.
Via
InvestorPlace
What's Going On With Pfizer Stock Today?
February 01, 2024
Pfizer stock update: Q4 earnings beat expectations with adjusted EPS of $0.10, while FY2023 shows a 72% YoY decline. Explore 2024 R&D plans and recent program discontinuations.
Via
Benzinga
Topics
Earnings
Exposures
Financial
Biotech And Medtech Portfolio Notes On A Fed Day
January 31, 2024
The Fed held rates keeping their future options flexible with no expectations for future cuts. The market did not like it and sold off with the Russell 2000 down 2.45% and the NASDAQ down 2.23%
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
3 Once-in-a-Lifetime Penny Stocks With Unprecedented Surge Potential
January 31, 2024
Is your portfolio is in dire need of making new all-time highs? A new economic cycle is to send these penny stocks with potential up.
Via
InvestorPlace
Listen to Wall Street and Buy These 3 Stocks Now
January 31, 2024
With a Wall Street recommended stock, you have the comfort of expert analysis along with a possible market-moving influence.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.